Filing Details
- Accession Number:
- 0001104659-21-011783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-03 20:22:46
- Reporting Period:
- 2021-02-01
- Accepted Time:
- 2021-02-03 20:22:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1774648 | Manu Chakravarthy | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | Svp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-01 | 60,000 | $0.00 | 60,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-01 | 18,472 | $5.50 | 41,528 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2021-02-01 | 60,000 | $0.00 | 60,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,000 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The restricted stock units vested in full on February 1, 2021.
Billionaire Hedge Funds
